154 related articles for article (PubMed ID: 32157316)
1. Bullous Pemphigoid in Three Paediatric Patients in Finland.
Pankakoski A; Panelius J; Salava A; Kluger N
Acta Derm Venereol; 2020 Mar; 100(6):adv00086. PubMed ID: 32157316
[No Abstract] [Full Text] [Related]
2. Methotrexate is safe and efficient as long-term treatment for bullous pemphigoid.
Delaumenie S; Assikar S; Prudhomme R; Matei I; Souyri N; Dalmay F; Bedane C
Eur J Dermatol; 2019 Apr; 29(2):217-218. PubMed ID: 30734720
[No Abstract] [Full Text] [Related]
3. Bullous pemphigoid masquerading as recurrent vesicular hand eczema.
Veien NK
Acta Derm Venereol; 2010; 90(1):4-5. PubMed ID: 20107717
[No Abstract] [Full Text] [Related]
4. Case of atypical bullous pemphigoid with generalized pruritus and eczema as the prodrome for 10 years.
Ikeda T; Okamoto K; Furukawa F
J Dermatol; 2012 Aug; 39(8):720-1. PubMed ID: 22011062
[No Abstract] [Full Text] [Related]
5. Type XVII collagen ELISA indices significantly decreased after bullous pemphigoid remission.
Kusajima E; Akiyama M; Sato M; Natsuga K; Shimizu H
Int J Dermatol; 2011 Feb; 50(2):238-40. PubMed ID: 21244398
[No Abstract] [Full Text] [Related]
6. [Bullous pemphigoid. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
Bernard P; Bedane C; Prost C; Ingen-Housz-Oro S; Joly P;
Ann Dermatol Venereol; 2011 Mar; 138(3):247-51. PubMed ID: 21397154
[No Abstract] [Full Text] [Related]
7. Dyshidrosiform pemphigoid restricted to the soles.
Hioki T; Shibata A; Makita S; Akiyama M
Int J Dermatol; 2018 Jun; 57(6):742-743. PubMed ID: 29624662
[No Abstract] [Full Text] [Related]
8. Dyshidrosiform palmoplantar pemphigoid in a young man: response to dapsone.
Lupi F; Masini C; Ruffelli M; Puddu P; Cianchini G
Acta Derm Venereol; 2010; 90(1):80-1. PubMed ID: 20107732
[No Abstract] [Full Text] [Related]
9. [Bullous pemphigoid: diagnosis and therapy].
Kneisel A; Hertl M
Wien Med Wochenschr; 2014 Sep; 164(17-18):363-71. PubMed ID: 25077677
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based management of bullous pemphigoid.
Daniel BS; Borradori L; Hall RP; Murrell DF
Dermatol Clin; 2011 Oct; 29(4):613-20. PubMed ID: 21925006
[TBL] [Abstract][Full Text] [Related]
11. Biological and Clinical Response to Omalizumab in a Patient with Bullous Pemphigoid.
Menzinger S; Kaya G; Schmidt E; Fontao L; Laffitte E
Acta Derm Venereol; 2018 Feb; 98(2):284-286. PubMed ID: 29136264
[No Abstract] [Full Text] [Related]
12. Bullous pemphigoid of infancy - report and review of infantile and pediatric bullous pemphigoid.
Ferreira BR; Vaz AS; Ramos L; Reis JP; Gonçalo M
Dermatol Online J; 2017 Feb; 23(2):. PubMed ID: 28329498
[TBL] [Abstract][Full Text] [Related]
13. Localized pemphigoid (pretibial type) with IgG antibody to BP180 NC16a domain successfully treated with minocycline and topical corticosteroid.
Kakurai M; Demitsu T; Azuma R; Yamada T; Suzuki M; Yoneda K; Ishii N; Hashimoto T
Clin Exp Dermatol; 2007 Nov; 32(6):759-61. PubMed ID: 17725660
[No Abstract] [Full Text] [Related]
14. Combination therapy of prednisolone and i.v. immunoglobulin treatment decreases circulating interleukin-5 and eosinophils in a patient with bullous pemphigoid.
Yamashita C; Nakamizo S; Honda Y; Dainichi T; Kabashima K
J Dermatol; 2017 Jan; 44(1):101-102. PubMed ID: 27154738
[No Abstract] [Full Text] [Related]
15. Coexistence case of bullous pemphigoid and pemphigus foliaceus.
Tsujiwaki M; Abe R; Nomura Y; Nishimura M; Hoshina D; Shinkuma S; Natsuga K; Ujiie H; Arita K; Shimizu H
Eur J Dermatol; 2013; 23(4):552-3. PubMed ID: 24001742
[No Abstract] [Full Text] [Related]
16. Acute blistering disease presenting IgG autoantibodies against NC16A and COOH-terminal domains of BP180 and laminin-332, with characteristic distribution of eruptions.
Kurashige Y; Minemura T; Nagatani T; Koga H; Hashimoto T
Eur J Dermatol; 2013; 23(1):109-10. PubMed ID: 23306276
[No Abstract] [Full Text] [Related]
17. Association between effective dose of prednisolone, alone or in conjunction with other immunosuppressants, and titre of anti-bullous pemphigoid 180 antibody: a retrospective study of 42 cases.
Miida H; Fujiwara H; Ito M
Clin Exp Dermatol; 2011 Jul; 36(5):485-8. PubMed ID: 21392080
[TBL] [Abstract][Full Text] [Related]
18. A case of childhood bullous pemphigoid with IgG and IgA autoantibodies to various domains of BP180.
Osawa M; Ueda-Hayakawa I; Isei T; Yoshimura K; Fukuda S; Hashimoto T; Okamoto H
J Am Acad Dermatol; 2014 Jun; 70(6):e129-31. PubMed ID: 24831331
[No Abstract] [Full Text] [Related]
19. Bullous pemphigoid in infancy with spontaneous remission.
Nomura H; Funakoshi T; Baba A; Tanikawa A; Hayakawa K; Amagai M
Eur J Dermatol; 2017 Feb; 27(1):95-96. PubMed ID: 27762214
[No Abstract] [Full Text] [Related]
20. A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid.
Amagai M; Ikeda S; Hashimoto T; Mizuashi M; Fujisawa A; Ihn H; Matsuzaki Y; Ohtsuka M; Fujiwara H; Furuta J; Tago O; Yamagami J; Tanikawa A; Uhara H; Morita A; Nakanishi G; Tani M; Aoyama Y; Makino E; Muto M; Manabe M; Konno T; Murata S; Izaki S; Watanabe H; Yamaguchi Y; Matsukura S; Seishima M; Habe K; Yoshida Y; Kaneko S; Shindo H; Nakajima K; Kanekura T; Takahashi K; Kitajima Y; Hashimoto K;
J Dermatol Sci; 2017 Feb; 85(2):77-84. PubMed ID: 27876358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
